COVID-19 vaccine study for healthy adults aged 18 to 64
Part of Infections, Lungs & breathing clinical trials.
This trial tests a COVID-19 vaccine in healthy adults to see how well it works. It may be an option if you are not at higher risk for severe COVID-19 and have not had COVID-19 in the past 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You are generally healthy and do not have medical conditions that make severe COVID-19 more likely.
- You have not tested positive for COVID-19 in the past 6 months (180 days).
- You have not recently received a vaccine and will not get another COVID-19 vaccine during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new COVID-19 vaccine designed to teach your immune system (T-cells) to fight the coronavirus. It is mainly for healthy adults who are not recently infected or vaccinated, to see how safe it is and how your immune system responds.
This study follows adults who have already received a COVID-19 vaccine to monitor side effects and safety over time. Your participation helps researchers understand how the vaccine affects different people who are at higher risk due to their work.
This study tests an experimental COVID-19 vaccine to see if it is safe and how well it works against current variants. It is for healthy adults who have had a previous COVID-19 vaccine or infection.
This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.
This study measures how strongly your immune system responds to COVID-19 vaccines. It includes people with newly diagnosed tuberculosis and a healthier comparison group, aiming to understand vaccine immune effects and safety.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
Hear when a new COVID-19 Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.